GlobalData epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. GlobalData epidemiologists attribute the growth in the diagnosed prevalent cases of AF in the 8MM to the changing population demographics in the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these markets.

1. EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023
Atrial fibrillation (AF) is a disorder of the hearts electrical system. AF is one of the most common cardiovascular diseases among the elderly, worldwide.
According to the Global Burden of Disease study, AF affected approximately 33.5 million people, or 0.5% of the world's population, in 2010, of which 20.9
million were men and 12.6 million were women. The disease burden is likely to increase in the near future due to the projected increase in the population,
especially the elderly population.
GlobalData epidemiologists forecast that the diagnosed prevalent cases of AF in the 8MM will grow by 21.8% over the next decade, from 10,112,797 diagnosed
prevalent cases in 2013 to 12,316,458 diagnosed prevalent cases in 2023. GlobalData epidemiologists attribute the growth in the diagnosed prevalent cases of AF
in the 8MM to the changing population demographics in the respective markets, rather than an actual increase in the diagnosed prevalence of AF in these markets.
GlobalDatas epidemiological forecast for the diagnosed prevalent cases of AF in the 8MM is supported by epidemiologic data from country-specific studies that
are nationally representative of the entire population in these markets. GlobalDatas epidemiological analysis included the most recently published
nationally-representative studies in the 8MM, which provided the diagnosed prevalence of AF using uniform diagnostic criteria based on EKG tests. Furthermore,
the diagnosed prevalent cases of AF in each of the 8MM were further segmented by age and sex to provide a more detailed analysis of the patient population. The
distribution of cases segmented by age and sex is important for understanding the burden of AF in various subgroups of the populations in each market, and for
achieving better management of the condition.
Scope
The Atrial fibrillation (AF) EpiCast Report provides an overview of the risk factors, comorbidities, and global trends of AF in the 8MM (US, France, Germany,
Italy, Spain, UK, Japan and Canada). It includes a 10-year epidemiological forecast for the diagnosed prevalent cases of AF segmented by age (ages =40 years),
sex, and clinical subtypes (paroxysmal, persistent, and permanent AF) in these markets. The AF epidemiology report is written and developed by Mastersand
PhD-level epidemiologists. The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 8MM.
Reasons to buy
Develop business strategies by understanding the trends shaping and driving the global AF market. Quantify patient populations in the global AF market to
improve product design, pricing, and launch plans. Organize sales and marketing efforts by identifying the sex and age groups that present the best opportunities
for AF therapeutics in each of the markets covered.
table Of Contents
1 Table Of Contents
1 Table Of Contents 4
1.1 List Of Tables 5
1.2 List Of Figures 6
2 Introduction 7
2.1 Catalyst 7
2.2 Upcoming Reports 7
3 Epidemiology 8
3.1 Disease Background 8
3.2 Risk Factors And Comorbidities 9
3.3 Global Trends 11
3.4 Forecast Methodology 13
3.4.1 Sources Used 15
3.4.2 Forecast Assumptions And Methods 21
3.4.3 Sources Not Used 25
3.5 Epidemiological Forecast For Atrial Fibrillation (2013-2023) 26
3.5.1 Diagnosed Prevalent Cases Of Atrial Fibrillation 26
3.5.2 Age-specific Diagnosed Prevalent Cases Of Atrial Fibrillation 28
3.5.3 Sex-specific Diagnosed Prevalent Cases Of Atrial Fibrillation 29
3.5.4 Age-standardized Diagnosed Prevalence Of Atrial Fibrillation 31
3.5.5 Diagnosed Prevalent Cases Of Atrial Fibrillation By Clinical Subtypes 32
3.6 Discussion 34
3.6.1 Epidemiological Forecast Insight 34
3.6.2 Limitations Of The Analysis 35
3.6.3 Strengths Of The Analysis 37
4 Appendix 38
4.1 Bibliography 38
4.2 About The Authors 42
EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023

2. 4.2.1 Epidemiologists 42
4.2.2 Reviewers 42
4.2.3 Global Director Of Epidemiology And Health Policy 43
4.2.4 Global Head Of Healthcare 44
4.3 About Globaldata 45
4.4 About Epicast 45
4.5 Disclaimer 46
ResearchMoz(http://www.researchmoz.us/) is the one stop online destination to find and buy market research reports & Industry Analysis. We fulfill all your
research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and
across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an
informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.
Contact:
M/s Sheela,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-997-4948
Email: sales@researchmoz.us
Website: http://www.researchmoz.us/
EpiCast Report: Atrial Fibrillation - Epidemiology Forecast to 2023